Cigna Group $CI Shares Bought by apricus wealth LLC

apricus wealth LLC boosted its holdings in shares of Cigna Group (NYSE:CI) by 715.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,505 shares of the health services provider’s stock after purchasing an additional 8,340 shares during the quarter. apricus wealth LLC’s holdings in Cigna Group were worth $2,616,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Brighton Jones LLC raised its stake in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC grew its stake in Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. Level Four Advisory Services LLC increased its holdings in Cigna Group by 3.2% in the 2nd quarter. Level Four Advisory Services LLC now owns 2,390 shares of the health services provider’s stock worth $790,000 after acquiring an additional 74 shares in the last quarter. Lido Advisors LLC increased its holdings in Cigna Group by 10.3% in the 2nd quarter. Lido Advisors LLC now owns 29,703 shares of the health services provider’s stock worth $9,820,000 after acquiring an additional 2,784 shares in the last quarter. Finally, Panagora Asset Management Inc. raised its position in Cigna Group by 59.8% during the second quarter. Panagora Asset Management Inc. now owns 189,801 shares of the health services provider’s stock worth $62,744,000 after acquiring an additional 71,034 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CI shares. Mizuho set a $325.00 target price on shares of Cigna Group in a research report on Friday, January 9th. Jefferies Financial Group upped their price target on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Finally, Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Price Performance

Cigna Group stock opened at $257.97 on Tuesday. The company has a fifty day simple moving average of $276.81 and a 200-day simple moving average of $279.82. The firm has a market capitalization of $67.98 billion, a price-to-earnings ratio of 11.63, a PEG ratio of 0.91 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a $1.56 dividend. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. Cigna Group’s dividend payout ratio is 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.